Statins may protect against hepatocellular carcinoma development in patients infected with hepatitis C virus, but what are the mechanisms?

J Clin Oncol. 2013 Nov 10;31(32):4160-1. doi: 10.1200/JCO.2013.51.0354. Epub 2013 Sep 30.

Authors

Sophie Clément¹, Marion Peyrou, Michelangelo Foti, Francesco Negro

Affiliation

¹ University Hospital, Geneva, Switzerland.

PMID: 24081939
DOI: 10.1200/JCO.2013.51.0354

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Hepatocellular / etiology*
Female
Hepatitis C / complications*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
Liver Neoplasms / etiology*
Male

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors